Intuitive announced unaudited preliminary financial results for the fourth quarter and full year of 2024 on January 15, 2025. In the fourth quarter, there was a significant 25% increase in revenue, totaling approximately $2.41 billion compared to $1.93 billion in the same period of 2023. The full year also saw a notable increase, with revenues reaching about $8.35 billion, up 17% from $7.12 billion in 2023. This growth was supported by a 17% increase in worldwide da Vinci procedures over the year, with a forecasted 13% to 16% increase in 2025. The company placed 1,526 da Vinci surgical systems during the year, marking an 11% increase from 2023.

The fourth quarter experienced robust growth in both procedures and system placements. Approximately 2,683,000 surgical procedures were performed using da Vinci systems in 2024, up from about 2,286,000 in 2023. System revenue for the quarter rose 36% to around $655 million, influenced by higher average selling prices and a lower mix of leased systems. The company also emphasized its contribution to the Intuitive Foundation, which increased to $45 million from $40 million in the prior year's fourth quarter.

Intuitive is optimistic about the future, focusing on enhancing patient outcomes through innovative platforms like da Vinci 5, Ion, and SP. The company did not experience significant disruptions from COVID-19 in 2024, which contrasts with the previous year’s impacts during the first quarter. With these strong preliminary results, Intuitive continues to be a leader in minimally invasive care and robotic-assisted surgery, shaping a future where healthcare is less invasive and more efficient.